XML 32 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2018
STOCKHOLDERS' EQUITY (Tables) [Line Items]  
Share-based expense [Table Text Block]
Share-based expense consisted of the following:

 

 

Three months ended

March 31,

 

 

2018

 

2017

Employee Awards

$

723,085

$

1,409,395

Consulting Awards

 

 

25,440

Feinsod Agreement

 

1,035,486

 

 

$

1,758,571

$

1,434,835

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2017

 

8,705,278

$

1.28

 

 

 

 

Granted

 

707,050

 

3.14

 

 

 

 

Exercised

 

(507,221)

 

0.87

 

 

 

 

Forfeited

 

(16,350)

 

2.45

 

 

 

 

Outstanding at March 31, 2018

 

8,888,757

 

1.45

 

2.1

$

8,909,000

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2018

 

7,113,307

$

1.13

 

1.8

$

8,541,000

 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2017

 

127,500

$

2.40

 

 

 

 

Exercised

 

(75,000)

$

1.31

 

 

 

 

Outstanding and exercisable
at March 31, 2018

 

52,500

$

1.54

 

0.9

$

35,375

 

 

Number of Shares

 

Weighted-average Exercise Price per Share

 

Weighted-average Remaining Contractual Term

(in years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2017

 

3,351,700

$

0.65

 

 

 

 

Exercised

 

(2,825,000)

$

0.52

 

 

 

 

Outstanding and exercisable
at March 31, 2018

 

526,700

$

1.36

 

3.4

$

566,260

Employee Awards  
STOCKHOLDERS' EQUITY (Tables) [Line Items]  
Schedule of Assumptions Used [Table Text Block]
The following summarizes the Black-Scholes assumptions used for Employee Awards granted during the three months ended March 31, 2018:

Exercise price

$ 2.21 – 7.17

Stock price on date of grant

$ 2.21 – 7.17

Volatility

140 %

Risk-free interest rate

2.17 – 2.36 %

Expected life (years)

2.5

Dividend yield